Skip to main content
  • Letter to the Editor
  • Open access
  • Published:

Blood brain barrier opening is not just blood-brain barrier opening

With great interest, we have read the recent publication of Tazhibi et al. “Focused ultrasound-mediated blood-brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma. J Transl Med. 2024 Mar 30;22(1):320”. The authors provide intriguing data on a combination of focused ultrasound (FUS) and hypofractionated radiotherapy for the opening of the blood-brain barrier (BBB) in the preclinical diffuse midline glioma (DMG) model. They demonstrated that the opening of BBB mediated through FUS in conjunction with radiotherapy was safe and feasible in rodents bearing DMG. To date, numerous groups have extensively explored the safety and feasibility of BBB opening however, only sparse research has been conducted to understand the consequent cellular and subcellular events in brain microvascular endothelial cells. The BBB is an integral part of the human brain’s physiology, and its integrity is maintained by the microvascular endothelial cells. A deep understanding of how these cells function during BBB opening in response to ultrasound is crucial for preserving brain homeostasis.

Specifically, it is known that ceramide, a bioactive sphingolipid, and its related enzyme acid sphingomyelinase (ASMase) can act as an important second messenger in endothelial cell signal transduction. Endothelial cells are known to express 20-fold higher secretory ASMase compared to other cells, making them a potential target in radiation response [1]. Evidence has demonstrated that various stress stimuli including focused ultrasound-stimulated microbubbles (FUS+MB) or radiotherapy can alter endothelial membranes causing hydrolyzation of sphingomyelin into ceramide via ASMase, consequently causing rapid endothelial apoptosis [2]. In contrast, endothelial cells pretreated with sphingosine-1-phosphate (S1P) (ceramide antagonist) can minimize ceramide-induced cell death effects. Moreover, extensive genetic studies altering host-animal vasculature by knock-out of ASMase demonstrate inhibition of microbubble-based endothelial damage in combination with enhancement [2].

It is reported that a single treatment of FUS+MB alone or radiation alone can elevate ceramide levels in endothelial cells causing its damage and these effects are known to be synergistically higher when both these treatment modalities are combined. Recently, in CNS-based studies, Fletcher et al. studied the therapeutic response of microbubble-mediated FUS combined with radiotherapy (4 Gy) in rats bearing F98 gliomas. It was observed that the FUS combined with radiotherapy demonstrated an apoptosis increase of  93% and 396% and a vessel-associated ceramide increase of 320% and 336% as compared to FUS or radiotherapy alone, respectively [3]. Thus, the presence of ceramide is associated with a significant impairment of endothelial cell function and viability.

Recent work conducted by Chen et al. demonstrated a radiation-enhancing effect in the CNS when FUS-mediated BBB-opening was combined with radiation in animal models and demonstrated applicability in patients [4]. Mechanistically, no investigations of ceramide production were undertaken there with the underlying radiation-enhancement remaining unaddressed. Similarly, here Tazhibi et al. have only conducted hematoxylin and eosin staining with no underlying immunohistochemistry investigating mechanisms. Careful examination of Fig. 3 (normal tissue) and Figs. 4, 5 (tumour) in the combined therapy (ultrasound-exposure and radiation) panels indicates an increased frequency of cell swelling, vacuolar degeneration, and eosinophilic neurons with pyknosis - consistent with potentially increased levels of cell death. Unfortunately, no immunohistochemistry or biochemical approaches pointing to an underlying biochemical mechanism for this are present. Brainstem hemorrhage and inflammation were studied, but those are gross morphological endpoints for study, not molecular assays of endothelial cell function.

The spate of genes involved in endothelial cell exposure to ultrasound and microbubbles has been characterized including genes responsible for acid and neutral-sphingomyelinase, cell-membrane lipid biogenesis, and caspase-family members responsible for apoptotic cell death with some seeing elevations up to 202.00±27.52 (ΔΔCt±SE) after exposure in vitro (supplementary information) [5]. The work has characterized the variety of ceramide species in response to ultrasound-stimulated exposure. In addition, endothelial cell function in response to microbubble exposure has been investigated to understand the physical effects of ceramide induction by microbubbles [5]. When combining ultrasound exposure for BBB opening such effects should be considered,

In short, taken en masse emerging research is demonstrating that the ultrasound parameters used in BBB opening do more than open the BBB. Whereas grossly the BBB may recover from FUS-BBB opening morphologically, ultrasound-stimulated microbubble exposure to the vasculature and endothelial cells has further extensive biochemical and molecular effects which make its combination with radiotherapy potentially cytotoxic in terms of significant radiation enhancement.

References

  1. Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell. 2005;8(2):89–91. https://doi.org/10.1016/j.ccr.2005.07.014. PMID: 16098459.

  2. El Kaffas A, Al-Mahrouki A, Hashim A, Law N, Giles A, Czarnota GJ. Role of Acid Sphingomyelinase and Ceramide in Mechano-Acoustic enhancement of Tumor Radiation responses. J Natl Cancer Inst. 2018;110(9):1009–18. https://doi.org/10.1093/jnci/djy011. PMID: 29506145; PMCID: PMC6136928.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Fletcher SP, Chisholm A, Lavelle M, Guthier R, Zhang Y, Power C, Berbeco R, McDannold N. A study combining microbubble-mediated focused ultrasound and radiation therapy in the healthy rat brain and a F98 glioma model. Sci Rep. 2024;14(1):4831. https://doi.org/10.1038/s41598-024-55442-6. PMID: 38413663; PMCID: PMC10899261.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Chen KT, Huang CY, Pai PC, Yang WC, Tseng CK, Tsai HC, Li JC, Chuang CC, Hsu PW, Lee CC, Toh CH, Liu HL, Wei KC. Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study. J Neurooncol. 2023;165(3):535-545. https://doi.org/10.1007/s11060-023-04517-x. Epub 2023 Dec 7. Erratum in: J Neurooncol. 2024;167(2):371. PMID: 38060066.

  5. Al-Mahrouki AA, Karshafian R, Giles A, Czarnota GJ. Bioeffects of ultrasound-stimulated microbubbles on endothelial cells: gene expression changes associated with radiation enhancement in vitro. Ultrasound Med Biol. 2012;38(11):1958–69. https://doi.org/10.1016/j.ultrasmedbio.2012.07.009. Epub 2012 Sep 12. PMID: 22980406.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Deepa Sharma or Gregory J. Czarnota.

Ethics declarations

Conflicts of interest

The authors have no conflicts of interest to declare.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sharma, D., Czarnota, G.J. Blood brain barrier opening is not just blood-brain barrier opening. J Transl Med 22, 660 (2024). https://doi.org/10.1186/s12967-024-05431-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12967-024-05431-0